Assessing the Response of Human NK Cell Subsets to Infection by Clinically Isolated Virus Strains

Overview

Journal Methods Mol Biol

Specialty Molecular Biology

Date 2022 Mar 28

PMID 35344177

Authors

Nobuyo Yawata

Makoto Yawata

Affiliations

Soon will be listed here.

Abstract

Natural killer (NK) cells play a critical role in defending against virus infections.Investigating human NK cell antiviral functions is of prime importance; however, there are challenges such as the human-specific nature of many viruses and differences in NK cell surface markers between humans and rodents. Research on the antivirus response of human NK cells must therefore be carefully planned around species tropism of the viruses of interest and the specific biological questions to be answered. The initial site of many virus infections is a mucosal/epithelial surface. In this context, a clinical virus infection at the ocular surface enables direct analyses on the mechanisms and consequences of infection and immune reactions in situ over the course of disease. For example, the site of infection of a clinical infection in the conjunctiva and cornea can be directly observed in real-time, utilizing split-lamp microscopy, and specimens are readily accessed with minimally invasive techniques.In this chapter, we describe protocols for investigating NK cell responses using clinically isolated viruses in co-culture assays. We also describe procedures for ex vivo analysis of conjunctiva-derived NK cells in adenovirus infection.

References

Hammer Q, Ruckert T, Romagnani C . Natural killer cell specificity for viral infections. Nat Immunol. 2018; 19(8):800-808. DOI: 10.1038/s41590-018-0163-6. View

Rothenburg S, Brennan G . Species-Specific Host-Virus Interactions: Implications for Viral Host Range and Virulence. Trends Microbiol. 2019; 28(1):46-56. PMC: 6925338. DOI: 10.1016/j.tim.2019.08.007. View

Karre K, Ljunggren H, Piontek G, Kiessling R . Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature. 1986; 319(6055):675-8. DOI: 10.1038/319675a0. View

Kim S, Poursine-Laurent J, Truscott S, Lybarger L, Song Y, Yang L . Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature. 2005; 436(7051):709-13. DOI: 10.1038/nature03847. View

Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J . Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2015; 9(1):159-70. DOI: 10.1038/mi.2015.47. View

Carrington M, Martin M, van Bergen J . KIR-HLA intercourse in HIV disease. Trends Microbiol. 2008; 16(12):620-7. PMC: 3463869. DOI: 10.1016/j.tim.2008.09.002. View

Yawata N, Shirane M, Woon K, Lim X, Tanaka H, Kawano Y . Molecular Signatures of Natural Killer Cells in CMV-Associated Anterior Uveitis, A New Type of CMV-Induced Disease in Immunocompetent Individuals. Int J Mol Sci. 2021; 22(7). PMC: 8037729. DOI: 10.3390/ijms22073623. View

Schust D, Tortorella D, Seebach J, Phan C, Ploegh H . Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. J Exp Med. 1998; 188(3):497-503. PMC: 2212475. DOI: 10.1084/jem.188.3.497. View

Vidal S, Khakoo S, Biron C . Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experience. Curr Opin Virol. 2011; 1(6):497-512. PMC: 3237675. DOI: 10.1016/j.coviro.2011.10.017. View

10.

Hage E, Wilkie G, Linnenweber-Held S, Dhingra A, Suarez N, Schmidt J . Characterization of Human Cytomegalovirus Genome Diversity in Immunocompromised Hosts by Whole-Genome Sequencing Directly From Clinical Specimens. J Infect Dis. 2017; 215(11):1673-1683. DOI: 10.1093/infdis/jix157. View

11.

Gonzalez G, Yawata N, Aoki K, Kitaichi N . Challenges in management of epidemic keratoconjunctivitis with emerging recombinant human adenoviruses. J Clin Virol. 2019; 112:1-9. DOI: 10.1016/j.jcv.2019.01.004. View

12.

Robinson C, Seto D, Jones M, Dyer D, Chodosh J . Molecular evolution of human species D adenoviruses. Infect Genet Evol. 2011; 11(6):1208-17. PMC: 3139803. DOI: 10.1016/j.meegid.2011.04.031. View

13.

Prichard M, Penfold M, Duke G, Spaete R, Kemble G . A review of genetic differences between limited and extensively passaged human cytomegalovirus strains. Rev Med Virol. 2001; 11(3):191-200. DOI: 10.1002/rmv.315. View

14.

Yamane S, Lee A, Hanaoka N, Gonzalez G, Kaneko H, Ishida S . Identification of contamination in the American type culture collection stock of human adenovirus type 8 by whole-genome sequencing. J Virol. 2012; 87(2):1285-6. PMC: 3554079. DOI: 10.1128/JVI.02875-12. View

15.

Yawata M, Murata S, Tanaka K, Ishigatsubo Y, Kasahara M . Nucleotide sequence analysis of the approximately 35-kb segment containing interferon-gamma-inducible mouse proteasome activator genes. Immunogenetics. 2001; 53(2):119-29. DOI: 10.1007/s002510100308. View

16.

He X, Draghi M, Mahmood K, Holmes T, Kemble G, Dekker C . T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus. J Clin Invest. 2004; 114(12):1812-9. PMC: 535070. DOI: 10.1172/JCI22797. View

17.

Lim D, Yawata N, Selva K, Li N, Tsai C, Yeong L . The combination of type I IFN, TNF-α, and cell surface receptor engagement with dendritic cells enables NK cells to overcome immune evasion by dengue virus. J Immunol. 2014; 193(10):5065-75. DOI: 10.4049/jimmunol.1302240. View

18.

Hammer Q, Ruckert T, Borst E, Dunst J, Haubner A, Durek P . Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells. Nat Immunol. 2018; 19(5):453-463. DOI: 10.1038/s41590-018-0082-6. View

19.

Robinson C, Singh G, Lee J, Dehghan S, Rajaiya J, Liu E . Molecular evolution of human adenoviruses. Sci Rep. 2013; 3:1812. PMC: 3648800. DOI: 10.1038/srep01812. View

20.

Ramke M, Lam E, Meyer M, Knipper A, Heim A . Porcine corneal cell culture models for studying epidemic keratoconjunctivitis. Mol Vis. 2013; 19:614-22. PMC: 3611943. View